Nuvilex, Inc. and Diabetes Research Institute Have Similar Approach to Islet Cell Transplantation
April 18, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Apr 18, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has "Cell-in-a-Box," the Diabetes Research Institute has BioHub. One is cell encapsulation technology, and the...
Xeris Pharmaceuticals Awarded Phase II Funding of NIH Fast -Track SBIR Grant to Advance Glucagon for the Artificial Pancreas
April 17, 2013 11:39 ET
|
Xeris Pharmaceuticals, Inc.
Austin, TX, April 17, 2013 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris"), an Austin-based,
pharmaceutical company developing patient-friendly injectable
treatments for diabetes and other...
Nuvilex, Inc. Expects its Technology Can Start to Change Life for Diabetics
April 08, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Apr 8, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) started its diabetes studies, it was likely well known then that while its late-stage pancreatic cancer trials are front...
Potential Future Sales of Nuvilex, Inc. Cancer Treatments Make Investment in Cell-in-a-Box Worth It
March 26, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Mar 26, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is a small biotechnology company out of Silver Spring, Maryland, but its future might be anything but small. As the company...
Timing Is Right for Big Pharma to Add Nuvilex, Inc. Technology to Its Pipeline
March 21, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Mar 21, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has close to $30-million invested in its "Cell-in-a-Box" technology, and as the company gets closer to the start of its...
Nuvilex, Inc. Diabetes Studies Could Eliminate Need for Daily Insulin Requirements
March 18, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Mar 18, 2013) - When investors look into biotechnology and pharmaceutical companies as an investment opportunity, three areas of research stand out as the most favorable...
American Geriatrics Society Identifies "Five Things" Healthcare Providers and Patients Should Question and Discuss
February 21, 2013 01:11 ET
|
American Geriatrics Society
NEW YORK, Feb. 21, 2013 (GLOBE NEWSWIRE) -- On February 21, the American Geriatrics Society (AGS) released its list of "Five Things Physicians and Patients Should Question," as part of the American...
Kerecis Announces a Distribution Agreement With Medline Industries for the MariGen Omega3 Tissue-Regeneration Technology
January 31, 2013 18:40 ET
|
Kerecis
DUBAI, UNITED ARAB EMIRATES--(Marketwire - Jan 31, 2013) - At the Arab Health Conference today, Kerecis announced the signing of a distribution agreement with Medline Industries, Inc., based in...
'Silver Cloud Diet' Fights Bad Fat With Good Fat
January 28, 2013 14:01 ET
|
Author Dr. John Salerno
NEW YORK, NY--(Marketwire - Jan 28, 2013) - Dr. John Salerno, protégé of the late "Atkins Diet" creator, Dr. Robert Atkins, corrects misconceptions about the science of nutrition and...
Bypass Surgery More Cost Effective Than Stents for Diabetics Long Term
November 04, 2012 21:12 ET
|
American Heart Association
Study Highlights:
Bypass surgery is more cost effective than drug-covered stents for people with diabetes who have multiple clogged heart arteries.
Initially, bypass surgery may cost more...